Yes, Dysport is a neurotoxin. Its active ingredient, abobotulinumtoxinA, is a purified form of botulinum neurotoxin type A, produced by the bacterium Clostridium botulinum. The FDA officially classifies Dysport as both an “acetylcholine release inhibitor” and a “neuromuscular blocking agent.” It belongs to the same family of neurotoxin-based drugs as Botox and Xeomin, all of which work through the same core protein to temporarily block nerve signals to muscles.
What “Neurotoxin” Actually Means Here
The word neurotoxin sounds alarming, but in this context it simply describes how the drug works. A neurotoxin is any substance that interferes with nerve function. Botulinum toxin type A does this by blocking the release of acetylcholine, a chemical messenger that nerves use to tell muscles to contract. When that signal is interrupted, the targeted muscle relaxes. The effect is temporary and localized to the area where the product is injected.
All three major botulinum toxin products on the market, Dysport, Botox, and Xeomin, rely on the same 150-kilodalton neurotoxin protein. That protein consists of two connected chains that work together: one binds to the nerve ending, and the other enters the nerve cell and disables its ability to release acetylcholine. The result is temporary muscle relaxation, which is the basis for both cosmetic and therapeutic uses.
How Dysport Is Used
Dysport is FDA-approved for both cosmetic and medical purposes. On the cosmetic side, it’s most commonly injected to soften frown lines between the eyebrows (glabellar lines). One session takes about 10 to 20 minutes, and results can appear in as little as 24 hours, though most people notice the effect within two to three days. The smoothing effect typically lasts up to five months.
On the medical side, Dysport treats conditions driven by excessive muscle activity, including cervical dystonia (involuntary neck muscle contractions), limb spasticity in both adults and children, and blepharospasm (uncontrollable eyelid twitching). In each case, the injections work by calming overactive muscles so patients can move more comfortably and participate in rehabilitation.
How Dysport Compares to Botox
Dysport and Botox contain the same type of neurotoxin, but they are not interchangeable at a one-to-one dose. The most widely supported conversion ratio is roughly 3 units of Dysport for every 1 unit of Botox. Earlier clinical practice sometimes used a 4:1 or even higher ratio, but research across conditions like spasticity, cervical dystonia, and blepharospasm consistently shows that a 3:1 ratio (or lower) produces equivalent results. Using a higher ratio can lead to excessive dosing, which increases the chance of side effects.
The two products also differ in their formulations and how they spread once injected, which can influence how a provider plans treatment. But the core mechanism, blocking acetylcholine release at the nerve-muscle junction, is identical.
Safety Risks to Know About
Dysport carries an FDA black box warning, the most serious type of safety alert. The warning addresses the possibility that the toxin’s effects can spread beyond the injection site, producing symptoms elsewhere in the body. These can include generalized muscle weakness, drooping eyelids, blurred or double vision, difficulty swallowing, changes in voice, and breathing problems. Swallowing and breathing difficulties can be life-threatening, and deaths have been reported.
These symptoms have appeared anywhere from hours to weeks after injection. The risk is highest in children treated for spasticity, but spread of effect has also been documented in adults across both approved and unapproved uses, sometimes at doses at or below the maximum recommended amount. People with pre-existing conditions affecting their muscles or nerves are more vulnerable.
Common, less serious side effects depend on where the injection is placed. For cosmetic frown line treatment, the most frequent complaints are injection-site reactions, headache, and temporary eyelid drooping. For medical uses involving higher doses, side effects can include swallowing difficulty, dry mouth, and muscle weakness near the treatment area.
Who Should Avoid Dysport
Dysport is made using a process involving cow’s milk protein (lactose is an inactive ingredient). Anyone with a known allergy to cow’s milk protein should not receive it. This is distinct from lactose intolerance, which is a digestive issue and not a concern here. The relevant risk is a true immune-mediated milk protein allergy.
People with a known hypersensitivity to any botulinum toxin product or to any other ingredient in Dysport should also avoid it. Those with infection at the proposed injection site need to wait until the infection resolves. And because the drug works by weakening muscles, people with conditions that already impair neuromuscular function, such as myasthenia gravis or Lambert-Eaton syndrome, face significantly higher risks from treatment.